We invest the majority of our fund in Europe and the rest in the US. We bridge the continents for our portfolio companies, facilitating partnerships and building international networks to help everyone succeed.
Europe & United States
Specialty Pharma, Biopharmaceuticals, Medical Devices, Diagnostics
From seed to public offerings
Potential for a strong exit within 4 to 6 years
€176M total; investments
of €7M to €10M
Will lead or co-lead an investment syndicate